IGM offers broad tech exposure with AI-driven growth, top holdings like AAPL and NVDA, and strong performance across sectors.

IGM Biosciences stock has experienced a significant decline, indicating an overall bearish sentiment in the market. The company's high expenses and poor financial management have devalued the company.

The iShares Expanded Tech Sector ETF (NYSEARCA:IGM) is a comprehensive ETF that gives investors exposure to the full spectrum of the North American tech sector, as it includes key tech-related stocks ...

4 analysts have expressed a variety of opinions on IGM Biosciences (NASDAQ:IGMS) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...

Investors might want to bet on IGM Biosciences, Inc. (NASDAQ:IGMS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $8.89, but opened at $8.51. IGM Biosciences shares last ...

IGM's combination of the in-house investment management groups from Mackenzie and Investors Group into a single shop (housed under the Mackenzie Investments brand) has enhanced the scale of the firm's ...

In the last three months, 5 analysts have published ratings on IGM Biosciences (NASDAQ:IGMS), offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of ...